Blackstone Inc. - EFFECTOR THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Blackstone Inc. ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$785,021
-27.7%
1,308,5870.0%0.00%
-40.0%
Q2 2023$1,086,389
+135.4%
1,308,5870.0%0.01%
+150.0%
Q1 2023$461,539
-17.5%
1,308,5870.0%0.00%0.0%
Q4 2022$559,552
+74606.5%
1,308,5870.0%0.00%
-33.3%
Q3 2022$749
-100.0%
1,308,5870.0%0.00%
-50.0%
Q2 2022$1,858,000
-64.6%
1,308,5870.0%0.01%
-53.8%
Q1 2022$5,248,000
-32.7%
1,308,5870.0%0.01%
-35.0%
Q4 2021$7,799,000
-57.6%
1,308,5870.0%0.02%
-51.2%
Q3 2021$18,386,0001,308,5870.04%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$4,025,0472.06%
Column Group LLC 4,026,224$2,415,3321.60%
OUP Management Co., LLC 1,025,697$615,3161.38%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,429,3480.28%
Carlyle Group Inc. 4,822,114$2,868,6760.12%
Sea Otter Advisors LLC 263,942$158,3390.09%
Parallel Advisors, LLC 1,693,559$1,015,9660.03%
Sonora Investment Management Group, LLC 125,000$74,9880.01%
Wescott Financial Advisory Group, LLC 30,556$18,3310.00%
Oasis Management Co Ltd. 100,000$59,9900.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders